TCS
neutral mediumTCS reported Q3 FY24 revenue of INR 63,583 crore, up 4% YoY, with operating margin expanding 70 bps sequentially to 25%.
Read TCS analysis →Side-by-side earnings comparison across financial stats, AI summaries, management guidance, risks, quotes, and accountability signals.
TCS reported Q3 FY24 revenue of INR 63,583 crore, up 4% YoY, with operating margin expanding 70 bps sequentially to 25%.
Read TCS analysis →HCLTech delivered a strong Q3 FY24 with 6% sequential revenue growth in constant currency, the highest since Q3 FY21.
Read HCLTech analysis →TCS reported Q3 FY24 revenue of INR 63,583 crore, up 4% YoY, with operating margin expanding 70 bps sequentially to 25%. Net profit stood at INR 11,735 crore, with net margin at 19.4%. Growth was driven by cloud and cybersecurity, with strong performance in India (+23.4% YoY) and UK (+8.1% YoY), while North America declined 3% due to macro uncertainties. Deal wins totaled $8.1 billion, broad-based without mega deals. Management noted no change in discretionary spending, with clients prioritizing cost optimization. GenAI is moving from POC to production with four deployments, but revenue impact remains small. Attrition improved to 13.3%. Guidance remains cautious; no specific revenue or margin targets given. Risk: prolonged weakness in North America and BFSI could delay recovery.
HCLTech delivered a strong Q3 FY24 with 6% sequential revenue growth in constant currency, the highest since Q3 FY21. Services revenue grew 3.1% QoQ despite furloughs, while software revenue rose 5% YoY. Operating margin improved to 19.8%, up 126 bps QoQ, driven by software outperformance. Net income reached a record INR 4,350 crore. Bookings YTD stood at $7.5 billion, up 10% YoY, with 18 large deals. Attrition fell to 12.8%, the lowest in several quarters. Management guided FY24 revenue growth of 5%-5.5% and margins of 18%-19%, with services expected at the higher end. Q4 growth is expected from large deal ramp-up, furlough reversal, and ER&D momentum. However, discretionary spending remains soft, and GenAI contributions are still nascent. A key risk is the uncertain demand environment in Americas and potential headwinds from macro uncertainty.
Order book closure for Q3, achieved without mega deals.
Attrition reduced from 14.9% in Q2, now in comfort range.
Driven by BSNL deal and positive seasonality.
Reflects market uncertainties; management expects recovery.
Year-to-date bookings grew 10% over the same period last year, driven by large deal wins.
Attrition declined 1.4 percentage points sequentially, reaching the lowest level since FY21.
Annual recurring revenue for software grew 2.9% year-over-year in constant currency.
The company signed 18 large deals in the quarter, including 6 in services and 12 in software.
Management expects BFSI to bottom out and grow from the coming quarter, driven by deal wins and seasonal bounce-back.
Management guidance growthBSNL deal will contribute over the next 4-6 quarters, with momentum picking up quarter on quarter.
Management guidance growthCFO stated that levers like productivity, utilization, and subcontractor costs offer further scope for improvement, though no specific target given.
Management guidance marginsCHRO reaffirmed the plan to onboard 40,000 freshers in FY24, with hiring progressing as per schedule.
Management guidance otherTotal revenue growth for FY24 is expected in the range of 5%-5.5% in constant currency, with services trending towards the higher end.
Management guidance revenueOperating margins for FY24 are expected to be between 18% and 19%.
Management guidance marginsQ4 services growth expected from large deal ramp-up, furlough reversal, ER&D momentum, and rest of portfolio.
Management guidance growthNorth America revenue declined 3% YoY and BFSI degrew 3% YoY. Management could not provide a timeline for recovery, citing macro uncertainties.
high · management_commentaryAnalyst noted that despite strong deal wins, revenue growth has been muted, partly due to reprioritization of older programs. Management confirmed this trend.
medium · analyst_questionGenAI is still in early stages with only four production deployments. Management could not provide a timeline for meaningful revenue contribution.
medium · analyst_questionHeadcount declined by 5,600 in Q3. CHRO said further decline would not be surprising, which could signal lower utilization or demand.
low · data_observationManagement noted that discretionary spending remains soft with no change from previous quarters, which could impact growth.
medium · management_commentaryDespite strong growth, the Americas demand environment remains challenging, which could affect future performance.
medium · management_commentaryGenAI programs are currently small and in pilot stages; significant ramp-up is expected only over coming quarters.
low · management_commentaryWage hikes impacted services margins by 65 bps in Q3, and Q4 will see a smaller impact of 20-25 bps.
low · analyst_questionOur revenues grew by 1.7% year-on-year and 1% quarter-on-quarter on a constant currency basis. Our rupee revenue grew by 4% to reach INR 63,583 crore.
Our continued focus on operational excellence helped us achieve an operating margin of 25%, which represents a sequential margin expansion of 75 basis points.
We have delivered a sixer of a quarter, with 6% constant currency growth quarter-on-quarter.
Our operating margins were strong at 19.8%, 126 basis points improvement sequentially, and 16 basis points improvement year-on-year.